Skip to main content

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Default content image

    In Memoriam: MJFF Mourns Loss of Parkinson’s Research Leader Ira Shoulson

    Ira Shoulson leaves behind a legacy of innovation and dedication that will continue to shape Parkinson’s research for years to come. His passing is a profound loss to the scientific community.  
    Learn more

  • Research Podcast Cover

    Episode 15: Innovative Fellowship Program is Training Tomorrow's Parkinson's Leaders with Rachel Dolhun

    The Edmond J. Safra Foundation and The Michael J. Fox Foundation created the Edmond J. Safra Fellowship in Movement Disorders with the goal of growing the global base of movement disorders…
    Learn more

  • Research Podcast Cover

    Episode 14: Evidence Linking Parkinson's Disease Risk and Environmental Exposure to Trichloroethylene (TCE) with Sam Goldman

    Dr. Sam Goldman discusses his research on environmental risk factors for Parkinson’s disease, focusing on recently published studies examining Parkinson's disease risk in veterans at Camp…
    Learn more

  • Two researchers in a lab

    What We Fund: $34.2M Toward Light Therapy for Sleep, Freezing of Gait and More

    The Michael J. Fox Foundation (MJFF) announces 63 grants that total more than $34.2 million awarded in February and March 2024.
    Learn more

  • Research Podcast Cover

    Episode 13: New Advances in Neurosurgical Interventions for Parkinson's Disease with Doris Wang

    With new technology and an ever-expanding understanding of the function of the nervous system and the pathophysiology of Parkinson's disease, neurosurgical interventions are becoming more…
    Learn more

  • Scientists Discover Potential Pathway of LRRK2 Dysfunction

    Results of Parkinson’s Trial for Diabetes Drug Lixisenatide Published

    In April 2024, the New England Journal of Medicine published results of a Phase 2 clinical trial of a diabetes drug lixisenatide, testing whether the medication could slow progression of Parkinson’s…
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.